Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders

Wehling, C.; Amon, O.; Bommer, M.; Hoppe, B.; Kentouche, K.; Schalk, G.; Weimer, R.; Wiesener, M.; Hohenstein, B.; Toenshoff, B.; Buescher, R.; Fehrenbach, H.; Goek, Oe. -N.; Kirschfink, M.

dc.contributor.author	Amon, Oliver
dc.date.accessioned	2018-04-05T14:21:57Z
dc.date.available	2018-04-05T14:21:57Z
dc.date.issued	2017
dc.identifier.issn	1365-2249
dc.identifier.uri	http://hdl.handle.net/10900/81302
dc.language.iso	en	de_DE
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/cei.12890	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01913
utue.publikation.seiten	304-315	de_DE
utue.personen.roh	Wehling, C.
utue.personen.roh	Amon, O.
utue.personen.roh	Bommer, M.
utue.personen.roh	Hoppe, B.
utue.personen.roh	Kentouche, K.
utue.personen.roh	Schalk, G.
utue.personen.roh	Weimer, R.
utue.personen.roh	Wiesener, M.
utue.personen.roh	Hohenstein, B.
utue.personen.roh	Toenshoff, B.
utue.personen.roh	Buescher, R.
utue.personen.roh	Fehrenbach, H.
utue.personen.roh	Goek, Oe. -N.
utue.personen.roh	Kirschfink, M.
dcterms.isPartOf.ZSTitelID	Clinical and Experimental Immunology	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	187	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE